WE SELL NOTHING✳EVERY CLAIM → A PRIMARY SOURCE✳UNKNOWN IS A REAL ANSWER✳NO PRODUCTS · NO PROTOCOLS · NO VENDORS✳WE SELL NOTHING✳EVERY CLAIM → A PRIMARY SOURCE✳UNKNOWN IS A REAL ANSWER✳
← All Claim Checks
Source record · FDA evidence review and small human study · reviewed July 18, 2026

Human research exists, but it does not establish DSIP as a proven insomnia treatment.

Misleading
The circulating claim

“DSIP is clinically proven to treat insomnia.”

What the source record says

Small intravenous human studies from the 1980s exist, including a six-person crossover study, but FDA describes the chronic-insomnia evidence as inconclusive and at best preliminary. FDA found no clinical data for the proposed subcutaneous route.

Why the claim misleads

The existence of old human studies is being treated as proof despite tiny samples, mixed results, short follow-up, and a route mismatch.

Correction

Human research exists, but it does not establish DSIP as a proven insomnia treatment.

Primary sources
FDA emideltide / DSIP briefing document, 2026Open source ↗Schneider-Helmert et al., 1981 — six-person crossover studyOpen source ↗Emideltide / DSIP library entryOpen source ↗
What changed

Added the source-verified Claim Check to the structured claim/source/change registry.

What would change our answer

A well-controlled human study tied to the exact product, population, route, and claimed outcome could change the answer. Mechanism, anecdotes, or a different product cannot substitute for that evidence.

Version history · 1 entry
  1. v1 · 2026-07-18Initial structured record created from the reviewed Claim Check.Source ↗
Boundary: This check evaluates a public claim. It does not assess an individual product or person and is not treatment, dosing, sourcing, or legal advice.